Home > Insider Trading > Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. (MIRM)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2024 Earnings Call Transcript

Operator: Hello everyone, and welcome to the Mirum Pharmaceuticals' Third Quarter 2024 Financial Results and Business Update. My name is Seb [ph] and I'll be the operator for your call today.

Keep Reading →

November 13th, 2024 - News Transcripts

8 Best Small-Cap Growth Stocks to Buy According to Analysts

During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.

Keep Reading →

October 22nd, 2024 - Hedge Funds News

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2024 Earnings Call Transcript

Operator: Hello, and welcome to the Mirum Pharmaceuticals First Quarter 2024 Financial Results and Business Update. My name is Terry, and I will be the conference operator today.

Keep Reading →

May 13th, 2024 - News Transcripts

Corporate Insiders Are Selling These 5 Small-Cap Stocks

This article presents an overview of Corporate Insiders Are Selling These 5 Small-Cap Stocks. For a detailed overview of such stocks, read our article, Corporate Insiders Are Selling These 10 Small...

Keep Reading →

March 27th, 2024 - Hedge Funds Insider Trading News

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q4 2023 Earnings Call Transcript

Mirum Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.66 EPS, expectations were $-0.33.

Keep Reading →

February 29th, 2024 - News Transcripts

Should You Invest in Mirum Pharmaceuticals (MIRM)?

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

January 15th, 2024 - Hedge Fund Investor Letters News

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2023 Earnings Call Transcript

Operator: Good afternoon. I would like to welcome you all to the Mirum Pharmaceuticals Conference Call. My name is Brika and I'll be the event specialist running today's call with you.

Keep Reading →

November 6th, 2023 - News Transcripts

Hedge Fund and Insider Trading News: Ken Griffin, Bill Ackman, D1 Capital Partners, Viking Global Investors, Sculptor Capital Management, Five Below Inc (FIVE), Globalstar, Inc. (GSAT), and More

D1 Capital Partners’s massive exposure to private bets is weighing on returns, making it one of the year’s worst-performing crossover funds.

Keep Reading →

September 13th, 2023 - Hedge Funds Insider Trading

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, and thank you all for joining. I would like to welcome you all to the Mirum Pharmaceuticals Report Second Quarter 2023 Financial Results and Provide Business Update.

Keep Reading →

August 11th, 2023 - News Transcripts

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2023 Earnings Call Transcript

Operator: Operator Ladies and gentlemen, welcome to the Mirum Pharmaceuticals Reports First Quarter 2023 Financial Results and Profile Business Update.

Keep Reading →

May 9th, 2023 - News Transcripts